Semaglutide and pioglitazone restore airway mucosal homeostasis by resolving Pseudomonas aeruginosa pyocyanin-induced mucus hypersecretion, ciliostasis, and type 2 airway inflammation
Authors:
Open Access
- 7 September 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1877061
Abstract
Rationale: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. As lung transplantation is the only curative option and current therapies are largely based on managing clinical symptoms, novel treatments are urgently needed. Objective: Previously, we showed that the first-generation incretin Exedine-4 could attenuate airway mucus dysregulation induced by the Pseudomonas aeruginosa redox-active toxin pyocyanin by modulating GLP1R-PPARγ signaling. In this study, we compared the efficacy of currently approved next-generation GLP1R agonists and PPARγ agonists in improving airway mucus homeostasis, mucociliary escalator function, and P . aeruginosa clearance after chronic exposure to pyocyanin, as well as the underlying mechanisms. Methods: Six GLP-1R agonists and two PPARγ agonists were compared based on their ability to attenuate pyocyanin-induced oxidative stress and mucin overexpression in 16HBE14o− cells by the cellular reactive oxygen species (ROS) assays, immunoblotting, and confocal immunofluorescence microscopy. The ability of these agonists to restore the mucociliary escalator function in air-liquid interface (ALI) cultures of primary human small airway epithelial cells (SAECs) was captured by confocal immunofluorescence microscopy. Then, we examined whether these agonists could restore mucus homeostasis, neutralize lung proinflammatory responses, and reduce bacterial burden in C57BL/6 mice. Finally, the expression of relevant pro- and anti-mucin biosynthesis signaling pathways was investigated. Measurements and main results: Semaglutide and Pioglitazone are the most effective in decreasing the expression of mucus biomarker MUC5AC mucin and ROS production in response to pyocyanin, both in vitro and in vivo . Additionally, these agonists restore mucociliary beat frequency and mucociliary transport impaired by pyocyanin. The protective effects of these drugs were partially abolished by respective antagonists, Exendin(9-39) and GW9662, against GLP1R and PPARγ, confirming the GLP1R signaling pathway-dependent mechanisms. Moreover, Semaglutide and Pioglitazone also attenuated type 2 immune responses and neutrophil influx, both of which are known drivers of mucus hypersecretion, and reduced the P. aeruginosa burden in a chronic bronchitis model of infection in mouse lungs. Conclusions: Our findings identify a promising adjunctive therapeutic avenue for COPD by repurposing FDA-approved Semaglutide and Pioglitazone, which are readily available for clinical use.Keywords
This publication has 75 references indexed in Scilit:
- Comparing Efficacy of Chiglitazar, Pioglitazone, and Semaglutide in Type 2 Diabetes: A Retrospective StudyDiabetes Therapy, 2025
- Pulmonary Mycosis Drives Forkhead Box Protein A2 Degradation and Mucus Hypersecretion through Activation of the Spleen Tyrosine Kinase–Epidermal Growth Factor Receptor–AKT/Extracellular Signal-Regulated Kinase 1/2 SignalingThe American Journal of Pathology, 2020
- Alcohol potentiates RSV-mediated injury to ciliated airway epitheliumAlcohol, 2019
- Semaglutide: First Global ApprovalDrugs, 2018
- GLP‐1 Receptor Agonists for Type 2 Diabetes Mellitus: Recent Developments and Emerging AgentsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014
- Co-Exposure to Cigarette Smoke and Alcohol Decreases Airway Epithelial Cell Cilia Beating in a Protein Kinase Cε-Dependent MannerThe American Journal of Pathology, 2012
- PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory PropertiesCell Metabolism, 2007
- Effects of rosiglitazone and metformin on pancreatic beta cell gene expressionDiabetologia, 2006
- Exendin‐4 differentiation of a human pancreatic duct cell line into endocrine cells: Involvement of PDX‐1 and HNF3β transcription factorsJournal of Cellular Physiology, 2002
- Pioglitazone time-dependently reduces tumour necrosis factor-α level in muscle and improves metabolic abnormalities in Wistar fatty ratsDiabetologia, 1998